期刊文献+

117例强直性脊柱炎病人注射英夫利西单抗的观察及护理 被引量:6

Observation and nursing care of 117 ankylosing spondylitis patients accepting infliximab injection
下载PDF
导出
摘要 [目的]探讨强直性脊柱炎病人静脉注射英夫利西单抗治疗时的护理。[方法]用注射用水溶解英夫利西单抗,配制时防止泡沫产生,现配现用;输液时使用精密过滤器;用输液泵或调速型输液器严格控制输液速度,先慢后快;使用前给病人测量生命体征,同时给予有效的护理干预。[结果]117例病人中,115例未发生不良反应,1例出现轻微头痛,1例出现变态反应,经治疗后症状得以缓解。[结论]有效的护理干预措施和严格的操作规程可明显减少英夫利西单抗治疗过程中不良反应的发生。 Objective:To probe into the observation and nursing care of 117 ankylosing spondylitis patients accepting infliximab injection. Methods:Using sterilized water for injection to dissolve infliximab injection,to avoid foaming during the process of dispensing and to use it right after it was ready. Precise filter was used during fluid infusion for patients. Infusion pump or speed - regulating infusion set was applied to control the infusion speed. That was slowly infusion for patients at beginning and fast later. Vital signs of all patients have been measured before and after injection. Meanwhile, effective nursing interventions were carried out for them. Results: Among all 117 patients,ll5 cases didn't have any adverse reactions. One case had minor headache. And only one case had allergic reaction. After treatment, symptoms of the case have been relieved. Conclusions:Effective nursing interventions and strict operations regulations can be significantly reduced the incidence of ad verse reactions during the course of treatment of ankylosing spondylitis pa tlents.
出处 《全科护理》 2009年第26期2359-2360,共2页 Chinese General Practice Nursing
关键词 强直性脊柱炎 英夫利西 单抗 护理 ankylosing spondylitis infliximab nursing
  • 相关文献

参考文献1

二级参考文献16

  • 1侯勇,张奉春,黄烽,吴东海,鲍春德,倪立青,姚晨.Infliximab治疗类风湿关节炎的随机双盲平行多中心临床试验[J].中华风湿病学杂志,2006,10(11):658-663. 被引量:34
  • 2王莉莎,黄烽,张江林,邓小虎,张亚美,张莉芸,郭军华.肿瘤坏死因子拮抗剂在治疗强直性脊柱炎中的安全性分析[J].中国新药杂志,2007,16(7):556-561. 被引量:24
  • 3CHOY EH, PANAYI GS. Cytokine pathways and joint inflammation in rheumatoid arthritis[J]. N Engl J Med, 2001, 344(12): 907-916.
  • 4RIGBY WF. Drug insight: different mechanisms of action of tumor necrosis factor antagonists-passive-aggressive benavior? [J]. Nat Clin Pract Rheumatol, 2007, 3(2): 227-233.
  • 5SCALLON B, CAI A, SOLOWSKI N, et al. Binding and functional comparisons of two types of tumor necrosis factor antagonists[J]. J Pharmacol Exp Ther, 2002, 301 (2): 418-426.
  • 6St CLAIR EW, van DER HEIJDE DM, SMOLEN JS, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial[J]. Arthritis Rheum, 2004, 50( 11 ) : 3432-3443.
  • 7GOEKOOP-RUITERMAN YP, de VRIES-BOUWSTRA JK, ALLAART CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study) : a randomized, controlled trial [J]. Arthritis Rheum, 2005, 52(11 ) : 3381-3390.
  • 8MAINI RN, BREEDVELD FC, KALDEN JR, et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate[J]. Arthritis Rheum, 2004, 50(4) : 1051-1065.
  • 9van DER BIJL AE, GOEKOOP-RUITERMAN YP, de VRIESBOUWSTRA JK, et al. Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis[J]. Arthritis Rheum, 2007, 56(7): 2129-2134.
  • 10van DER HEIJDE D, DIJKMANS B, GEUSENS P, et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)[J]. Arthritis Rheum. 2005 Feb; 52(2): 582-591.

共引文献39

同被引文献44

  • 1邓小虎,黄烽.英夫利西单抗治疗炎性关节病的研究进展[J].中国药物应用与监测,2006,3(6):10-14. 被引量:17
  • 2向葵.类克静脉输注护理流程探讨[J].求医问药(下半月),2013(8):260-261. 被引量:1
  • 3白月玲,马双莲.护士临床用药中的安全管理[J].中国护理管理,2006,6(4):14-16. 被引量:108
  • 4OLSEN N J. STEIN C M. New drugs for rheumatoid arthritis [J]. N EnglJ Meal,2004, 350(21): 2167.
  • 5GARRISON L, McDONNELL N D. Etanercept: therapeutic use in patients with rheumatoid arthritis[J]. Ann Rheum Dis, 1999, 58(Suppl 1): 165.
  • 6H aens D R. Infliximab as disease modifying therapy[J ]. Eur J Gastroenterol Hepatol, 2003, 15(3): 233.
  • 7Vander Heijde D, Dijkmans B, Geusens P, et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis re- sults of a randomized, placebo - controlled trial(ASSERT) [J ].Arthritis Rheum, 2005, 52(2): 582.
  • 8Harriman G, Harper L K, Schaible T H. Summary of clinical trials in rheumatoid arthritis using infliximab, an anti- TNF a trot- ment[J]. N EnglJmed, 2000, 343(22): 1594.
  • 9陈晓宁,孟明.病原生物学与免疫学基础[M].北京:人民军医出版社,2010:30.
  • 10安艳.病原生物学与免疫学基础[M].北京:人民军医出版社,2012:53.

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部